SciELO - Scientific Electronic Library Online

 
vol.34 número6Incidencia de bacterias multi-resistentes en unidades de cuidados intensivos de hospitales chilenosDeclaración del Comité Consultivo de Inmunizaciones de Sociedad Chilena de Infectología en relación a los cuestionamientos de las vacunas y su obligatoriedad índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • En proceso de indezaciónCitado por Google
  • No hay articulos similaresSimilares en SciELO
  • En proceso de indezaciónSimilares en Google

Compartir


Revista chilena de infectología

versión impresa ISSN 0716-1018

Resumen

GONZALEZ M, Claudio et al. Safety of fluoroquinolones: risks usually forgotten for the clinician. Rev. chil. infectol. [online]. 2017, vol.34, n.6, pp.577-582. ISSN 0716-1018.  http://dx.doi.org/10.4067/S0716-10182017000600577.

Quinolones are a group of widely used antimicrobials. Although they are considered safe for patients, knowledge of the safety profile is necessary so that professionals become aware of what is necessary to monitor. At the musculoskeletal level, quinolones have the potential to damage cartilage, causing even tendon rupture in infrequent cases. Hypoglycemia / hyperglycemia has been observed at the endocrine level, thus, careful monitoring of glycemia in patients with quinolone is recommended in diabetic patients. At the cardiovascular level, arrhythmias induced by these antimicrobials are rare but severe. At the level of the nervous system, the appearance of alterations of the central nervous system and the peripheral neuropathy are emphasized. When assessing the safety of quinolones, it is important to consider potential interactions with other substances (medical products). In children it is preferred not to use fluoroquinolones because of the potential risk of cartilage damage and growth, effects that do not seem to be so dramatic in the face of new evidence. Despite optimism, the safety of the treatment of these antimicrobials should be evaluated in every pediatric patient.

Palabras clave : Fluoroquinolonas; safety; pharmaco surveillance; pediatrics.

        · resumen en Español     · texto en Español     · Español ( pdf )